VAERS Explorer
Back to explore

Report #2892977

Received Apr 16, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
LA
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNKUT879MA—

Symptoms (2)

No adverse eventProduct storage issue

Symptom narrative

patient was given vaccine with this post-excursion with no AE; Initial information received on 01-Apr-2026 regarding an unsolicited valid non-serious case received from a healthcare professional (HCP). This case involves a patient of unknown age and unknown gender who received influenza USP trival A-B subvirion no preservative vaccine (Fluzone NP) with this post-excursion with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), family history were not provided. On an unknown date, the patient received a dose of unknown frequency of influenza USP trival A-B subvirion no preservative vaccine [Fluzone] suspension for injection (batch/lot number: UT879MA, expiry date: 30-Jun-2026) (strength: unknown) via unknown route in an unknown administration site for influenza (influenza immunization) post excursion with no adverse event (poor quality product administered, onset: unknown, latency: same day). Action taken: not applicable.

Medical history

Comments: NONE